Luc Mainville

Luc Mainville founded LUMA Capital LLC.
Mr. Mainville also currently works at ChitogenX, Inc., as Chief Financial Officer & Senior Vice President from 2018, LUMA Life, Inc., as President from 2015, and LSL Pharma Group, Inc., as Chief Financial Officer & Senior Vice President from 2023.
Mr. Mainville also formerly worked at LAB Research, Inc., as President, Chief Executive Officer & Director from 2006 to 2011, Neopharm Labs, Inc., as President & Chief Executive Officer from 2012 to 2015, Power Tech Corp., Inc., as Chairman from 2010 to 2011, BIOTECanada, as Vice Chairman from 2010 to 2012, BioAxone Therapeutic, Inc., as Chairman in 2007, Zucara Therapeutics, Inc., as Chairman from 2017 to 2020, Enobia Pharma, Inc., as Director, BANGI, Inc., as Director from 2007 to 2008, Alethia Biotherapeutics, Inc., as Director from 2008 to 2011, Acerus Pharmaceuticals Corp., as Director in 2018, AAA Medic Montreal, Inc., as Director, Correvio Pharma Corp., as Senior Vice President in 2016, LAB International, Inc., as Chief Financial & Operating Officer from 2003 to 2006, Waratah Pharmaceuticals, Inc., as CFO, Vice President-Finance & Administration from 2000 to 2002, KPMG LLP, as SVP & Partner-Corporate Finance Group from 1995 to 1998, SkyePharma Canada, Inc., as Chief Financial Officer from 1998 to 2001, URRMA Biopharma, Inc., as CFO, Vice President-Finance & Administration from 2002 to 2003, Valeo Pharma, Inc., as Chief Financial Officer & Senior Vice President from 2018 to 2023, and Manitex Capital, Inc., as Principal.
Mr. Mainville received his Masters Business Admin degree in 1992 from McGill University and undergraduate degree in 1987 from the University of Quebec.